IBIO · iBio, Inc.
AI read · Good for IBIO
The AI's read
These results give iBio a promising reason to keep developing IBIO-610, since preserving muscle may matter to people losing weight. But the study involved monkeys, not people, and each group was small. iBio plans to begin testing in people in 2027, so the results have not shown whether the drug works in humans.